Der-Yuan Chen is the Vice Superintendent of the Rheumatology and Immunology Center, China Medical University Hospital, Taiwan. He is also a professor of Medicine at China Medical University, Taiwan. In the past 15 years, Dr. Chen’s Lab has focused on research related to rheumatology, immunogenetics, molecular immunology, and risk management of biological therapy. The research directions mainly include (1) Insights into the immunopathogenesis of autoimmune diseases (SLE, RA, and idiopathic inflammatory myopathy) and auto-inflammatory disease (adult-onset Still’s disease); (2) Evaluation of virus infection such as human parvovirus B19 with inflammatory diseases; (3) Identification of diagnostic or predictive biomarkers in rheumatic diseases; and (4) Investigation of clinical implication or safety profile of therapies with biologics or small molecular inhibitors. In the past year, Dr. Chen’s Lab has also conducted a study regarding virus infection or stem cell therapy on disease animal models. In the recent 15 years, more than 180 SCI articles related to inflammatory diseases have been published.
Research Keywords & Expertise
Geriatrics
Immunology
Internal Medicine
Molecular Biology
Rheumatology
Short Biography
Der-Yuan Chen is the Vice Superintendent of the Rheumatology and Immunology Center, China Medical University Hospital, Taiwan. He is also a professor of Medicine at China Medical University, Taiwan. In the past 15 years, Dr. Chen’s Lab has focused on research related to rheumatology, immunogenetics, molecular immunology, and risk management of biological therapy. The research directions mainly include (1) Insights into the immunopathogenesis of autoimmune diseases (SLE, RA, and idiopathic inflammatory myopathy) and auto-inflammatory disease (adult-onset Still’s disease); (2) Evaluation of virus infection such as human parvovirus B19 with inflammatory diseases; (3) Identification of diagnostic or predictive biomarkers in rheumatic diseases; and (4) Investigation of clinical implication or safety profile of therapies with biologics or small molecular inhibitors. In the past year, Dr. Chen’s Lab has also conducted a study regarding virus infection or stem cell therapy on disease animal models. In the recent 15 years, more than 180 SCI articles related to inflammatory diseases have been published.
